Gene · 3229
Papers1,422
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,422
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| METTL1-mediated m7G modification regulates hair follicle cycle via the HOXC13/FOXN1/DSG4 axis. | PLoS Genet | 2026 | 42771602 | PubTator, text mining | PubMed |
| Ubiquitin-Proteasome System-Related Prognostic Model and Immune Landscape in Glioblastoma. | Int J Genomics | 2026 | 42488132 | PubTator, text mining | PubMed |
| Hoxc13 and homologs of mammalian hair keratins are required for the cornification of nuptial pads in Xenopus frogs. | Commun Biol | 2026 | 42323399 | PubTator, text mining | PubMed |
| HOXC4 Is Associated with the Prognosis and Immune Cell Infiltration in the Progression of Prostate Cancer. | Curr Gene Ther | 2026 | 42227542 | PubTator, text mining | PubMed |
| Injectable polysaccharide-based hydrogel delivering Poria cocos extracellular vesicles promotes hair regeneration in androgenetic alopecia via Wnt/β-catenin signaling. | Int J Biol Macromol | 2026 | 42142777 | PubTator, text mining | PubMed |
| New Cyclopeptides and Curvularins from Marine-Derived Fungal-Bacterial Symbiont Aspergillus spelaeus GXIMD 04541/Sphingomonas echinoides GXIMD 04532. | Mar Drugs | 2026 | 41892970 | PubTator, text mining | PubMed |
| A 7-gene expression signature predicts immune microenvironment remodeling and neoadjuvant chemo-immunotherapy response in lung squamous cell carcinoma. | Front Immunol | 2026 | 41836378 | PubTator, text mining | PubMed |
| Androgen Signaling Represses Homeobox C9, an Inhibitor of Androgen Receptor, in Prostate Cancer Cells. | Int J Mol Sci | 2026 | 41752098 | PubTator, text mining | PubMed |
| Integrative transcriptomic and machine learning analysis identifies CDH17 and HOXC13 as robust candidate prognostic biomarkers in uveal melanoma. | Comput Biol Med | 2026 | 41740484 | PubTator, text mining | PubMed |
| Pure Hair-Nail Ectodermal Dysplasia: Expanding the HOXC13 Genotypic Spectrum. | Pediatr Dermatol | 2026 | 41714886 | PubTator, text mining | PubMed |
| Human messenger RNA harbors widespread noncoding splice isoforms. | Brief Bioinform | 2026 | 41697920 | PubTator, text mining | PubMed |
| Mutational spectrum of EDA, EDAR, EDARADD, and WNT10A genes in the largest cohort of Russian patients with hypohidrotic ectodermal dysplasia. | Orphanet J Rare Dis | 2026 | 41645317 | PubTator, text mining | PubMed |
| Multiomic analysis of colorectal adenocarcinoma reveals a new subtype of myofibroblastic cancer-associated fibroblasts that express high levels of B7-H3 and have poor-prognosis value. | J Immunother Cancer | 2026 | 41629132 | PubTator, text mining | PubMed |
| Prediction of Clinical Outcomes and Immunotherapy Response in Breast Cancer Based on T Cell-Mediated Tumor Killing-Related Traits. | Endocr Metab Immune Disord Drug Targets | 2026 | 41603185 | PubTator, text mining | PubMed |
| Effects of LncRNA HOXC13-AS on the Prognosis of Non-small Cell Lung Cancer Patients and Its Mechanism of Disease Progression. | Biochem Genet | 2026 | 41296139 | PubTator, text mining | PubMed |
| The effect of smartphone texting on cervical spine sagittal alignment in healthy young adults. | J Spine Surg | 2025 | 41509843 | PubTator, text mining | PubMed |
| Automated detection of cylindrical structures in complex pipelines using iterative point cloud segmentation and high-precision fitting. | Sci Rep | 2025 | 41310248 | PubTator, text mining | PubMed |
| [Clinical characteristics and genotype analysis of two rare subtypes of acute myeloid leukemia]. | Zhonghua Yi Xue Za Zhi | 2025 | 41218897 | PubTator, text mining | PubMed |
| Developing age-friendly spaces through a gerontechnological lens: a systemic framework based on FDM-DANP analysis. | Front Med (Lausanne) | 2025 | 41158455 | PubTator, text mining | PubMed |
| Integrated Meta-Analysis of Scalp Transcriptomics and Serum Proteomics Defines Alopecia Areata Subtypes and Core Disease Pathways. | Int J Mol Sci | 2025 | 41096925 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3229/papers